| Product Code: ETC12702709 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Nuclear Medicines Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Nuclear Medicines Market - Industry Life Cycle |
3.4 Latvia Nuclear Medicines Market - Porter's Five Forces |
3.5 Latvia Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.7 Latvia Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Latvia Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Latvia Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine for diagnosis and treatment |
4.2.2 Technological advancements in nuclear medicine imaging and therapies |
4.2.3 Growing investments in healthcare infrastructure and facilities in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the use and disposal of nuclear medicines |
4.3.2 High costs associated with nuclear medicine equipment and procedures |
4.3.3 Limited availability of skilled professionals in the field of nuclear medicine in Latvia |
5 Latvia Nuclear Medicines Market Trends |
6 Latvia Nuclear Medicines Market, By Types |
6.1 Latvia Nuclear Medicines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Nuclear Medicines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Nuclear Medicines Market Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031F |
6.1.4 Latvia Nuclear Medicines Market Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031F |
6.2 Latvia Nuclear Medicines Market, By Application Area |
6.2.1 Overview and Analysis |
6.2.2 Latvia Nuclear Medicines Market Revenues & Volume, By Oncology Imaging, 2021 - 2031F |
6.2.3 Latvia Nuclear Medicines Market Revenues & Volume, By Thyroid Treatment, 2021 - 2031F |
6.2.4 Latvia Nuclear Medicines Market Revenues & Volume, By Cardiac Imaging, 2021 - 2031F |
6.2.5 Latvia Nuclear Medicines Market Revenues & Volume, By Bone Pain Palliation, 2021 - 2031F |
6.3 Latvia Nuclear Medicines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Latvia Nuclear Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Latvia Nuclear Medicines Market Revenues & Volume, By Endocrinology Clinics, 2021 - 2031F |
6.3.4 Latvia Nuclear Medicines Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F |
6.3.5 Latvia Nuclear Medicines Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 Latvia Nuclear Medicines Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 Latvia Nuclear Medicines Market Revenues & Volume, By Technetium-99m, 2021 - 2031F |
6.4.3 Latvia Nuclear Medicines Market Revenues & Volume, By Iodine-131, 2021 - 2031F |
6.4.4 Latvia Nuclear Medicines Market Revenues & Volume, By Thallium-201, 2021 - 2031F |
6.4.5 Latvia Nuclear Medicines Market Revenues & Volume, By Samarium-153, 2021 - 2031F |
7 Latvia Nuclear Medicines Market Import-Export Trade Statistics |
7.1 Latvia Nuclear Medicines Market Export to Major Countries |
7.2 Latvia Nuclear Medicines Market Imports from Major Countries |
8 Latvia Nuclear Medicines Market Key Performance Indicators |
8.1 Adoption rate of new nuclear medicine technologies in healthcare facilities |
8.2 Number of research and development collaborations in nuclear medicine sector |
8.3 Patient outcomes and satisfaction levels post nuclear medicine procedures. |
9 Latvia Nuclear Medicines Market - Opportunity Assessment |
9.1 Latvia Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.3 Latvia Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Latvia Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Latvia Nuclear Medicines Market - Competitive Landscape |
10.1 Latvia Nuclear Medicines Market Revenue Share, By Companies, 2024 |
10.2 Latvia Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here